RxDoctor Payments Data

Nicholas Hathaway

Family · Summerville, SCNPI 1003431511

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $558 and has fallen 93.3% since, to $37 in 2024.

$938in general payments, 2019–2025

Across 55 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$93
  • Otsuka America Pharmaceutical, Inc.$90
  • Takeda Pharmaceuticals U.S.A., Inc.$70
  • Novo Nordisk$67
  • Dexcom, Inc.$62
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$61
  • plus $495 from 16 others

What the payments were for

  • Food & beverage$938100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$938 in reported general payments places this provider in the 65th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina →

Other family in Summerville

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →